MRG-001: Clinical Trials

4 trials of MRG-001, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 not yet recruiting. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 2, Completed 1, Not yet recruiting 1

Follow MRG-001: new trials by email Literature Review of MRG-001 trials Research Report on MRG-001

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MRG-001 in Patients With Amyotrophic Lateral Sclerosis
MRG-001 - Amyotrophic Lateral Sclerosis, Lou Gehrig Disease
Phase 2UnknownMedRegen LLC102025-07-012024-08-23
MRG-001 in Patients With Alcoholic Hepatitis
MRG-001 - Alcoholic Hepatitis, Acute Alcoholic Hepatitis
Phase 2Not yet recruitingMedRegen LLC322024-09-012024-03-13
Safety and Efficacy of MRG-001 in Wound Healing in Abdominoplasty Patients
MRG-001, Saline - Wound of Skin, Abdominal Wound
Phase 2CompletedMedRegen LLC102023-11-202025-09-08
MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients
MRG-001, Placebo - COVID-19, ARDS, Human
Phase 2UnknownMedRegen LLC402021-12-012022-02-15

Conditions studied

Amyotrophic Lateral Sclerosis (1)  ·  COVID-19 (1)  ·  Hepatitis, Alcoholic (1)  ·  Infections (1)  ·  Liver Diseases, Alcoholic (1)  ·  Motor Neuron Disease (1)  ·  Respiratory Distress Syndrome (1)

Sponsors

MedRegen LLC (4)

Countries

United States (2)

Top investigators

Ali R Ahmadi, MD PhD (2)  ·  Robert D Galiano, MD FACS (1)  ·  Russell N Wesson, M.B.Ch.B (1)

Results publications

PMID 37633275